The use of direct oral anticoagulants in subgroups of patients with specific characteristics
The paper is focused on the issues of using direct oral anticoagulants (DOACs) in the subgroups of patients with specific characteristics. The current data on the effects of DOACs in such patients during anticoagulant therapy aimed at prevention of thromboembolic complications in both patients with...
Saved in:
Main Authors: | Sergey R. Gilyarevsky (Author), Maria V. Golshmid (Author), Nana G. Bendeliani (Author), Irina M. Kuzmina (Author) |
---|---|
Format: | Book |
Published: |
LLC "MEDIAFORMAT",
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
History of combined protection: 25 years of using the fixed-dose combination of amlodipine and bisoprolol in clinical practice
by: Sergey R. Gilyarevsky, et al.
Published: (2022) -
Current insights into the possible role of laboratory monitoring of effectiveness and safety of direct oral anticoagulants
by: S. R. Gilyarevsky, et al.
Published: (2023) -
Clinically Significant Drug Interactions for Direct Oral Anticoagulants: State of the Art
by: S. R. Gilyarevsky
Published: (2022) -
«Prescribe not prescribe»: the role of β-blockers in modern treatment of patients with arterial hypertension and concomitant disorders
by: Sergey R. Gilyarevsky, et al.
Published: (2024) -
Therapeutic Options for the Single Pill Combination of Lisinopril, Amlodipine and Rosuvastatin: a Systematic Review
by: S. R. Gilyarevsky, et al.
Published: (2022)